3187 results for «2265»
3187 results
Repeat TAVI
09 Feb 2025 – From PCR Tokyo Valves 2025
Delve into the world of repeat TAVI in this insightful session. Gain a comprehensive understanding of the predicted surge in valve-in-valve volume, the various causes of TAVI dysfunction requiring re-intervention, and the comparative performance of balloon-expandable and self-expandable valves for percutaneous treatment of failed aortic valve...
TAVI challenging cases
09 Feb 2025 – From PCR Tokyo Valves 2025
Delve into this session showcasing challenging TAVI cases and innovative solutions. Witness a successful TAVI case with immediate valve implantation following BAV in a severely calcified aortic valve. Explore a case where VR simulation helped enable easier coronary access during PCI after TAVI. Discover the management...
TAVI burning issues
09 Feb 2025 – From PCR Tokyo Valves 2025
This comprehensive session delves into the 'burning issues' in TAVI, covering a wide range of topics. Discover the impact of catheter insertion on left ventricular pacing, the importance of the en-face view for coronary cannulation, comparisons of TAVI valve expansions, indications for left and right ventricular...
Mitral valve interventions cases
09 Feb 2025 – From PCR Tokyo Valves 2025
This session delves into the latest advancements in minimally invasive mitral valve interventions. Explore a range of cutting-edge techniques, including 4D intracardiac echocardiography-guided mitral valve-in-valve procedures, valve-in-ring for severe mitral stenosis, pre-emptive tip to base LAMPOON in valve-in-ring TMVR, and chordal mapping with live multi-planar reconstruction...
Imaging in TAVI
09 Feb 2025 – From PCR Tokyo Valves 2025
This session delves into the latest advancements in imaging for TAVI, covering a range of topics. Discover insights into clinical outcomes in patients with very low-gradient severe aortic stenosis after TAVI, the influence of TAVI valve differences on long-term outcomes in left ventricular mass index, the...
Indication and device selection for tricuspid interventions
09 Feb 2025 – From PCR Tokyo Valves 2025
Want to sharpen your skills in selecting the right patients and devices for transcatheter tricuspid interventions? Don’t miss this session!
Learn how to assess anatomical suitability for T-TEER and TTVR, identify patients who may benefit from replacement over repair and explore the latest insights on timing and...
Periprocedural management: TAVI
09 Feb 2025 – From PCR Tokyo Valves 2025
Want to elevate your expertise in TAVI periprocedural management? This session (in Japanese) is for you!
Discover the essential skills every team member needs for a smooth and successful TAVI procedure. Learn how radiologic technologists optimize imaging, how medical laboratory technologists provide critical real-time data, and how...
Valvular interventions
09 Feb 2025 – From PCR Tokyo Valves 2025
Explore the latest insights and advancements in valvular interventions in this comprehensive session. Dive into the medical cost analysis of TAVR versus SAVR in Japanese dialysis patients, the long-term outcomes of Myval valve implantation in the pulmonary position, the comparative effectiveness of balloon aortic valvuloplasty techniques,...
Tricuspid and pulmonary valve intervention
09 Feb 2025 – From PCR Tokyo Valves 2025
Delve into the challenges and innovations in tricuspid and pulmonary valve interventions. Discover cases involving imaging nightmares for treating severe tricuspid regurgitation, transcatheter pulmonary valve implantation for heavily calcified lesions, and the use of the "zipping technique" for massive tricuspid valve flail gaps. Explore the strategies...
Lifetime management with self-expandable valve based on the latest evidence
09 Feb 2025 – From PCR Tokyo Valves 2025
Explore the latest evidence on the Evolut system and its impact on long-term valve durability in TAVR. Gain insights into its use for TAV-in-SAV procedures, the role of valve design in optimizing outcomes, and the importance of first-valve selection, commissure alignment, and coronary access.
TAVI abstracts
09 Feb 2025 – From PCR Tokyo Valves 2025
Delve into the latest TAVI-related research and advancements. Explore studies on optimizing hemostasis during TAVI, the safety and efficacy of TAVI in Filipino patients, the outcomes of TAVI in hemodialysis patients, and the effectiveness of patient education videos for TAVI. Stay up-to-date with the latest developments...
M-TEER for challenging anatomy
09 Feb 2025 – From PCR Tokyo Valves 2025
Delve into the world of M-TEER for challenging anatomies. Understand the types of complex anatomies, the associated risks of complications, and learn how to select the appropriate TEER strategy for patients with small left atria, large gaps, and giant left atria. Gain valuable insights to optimize...
Mitral and tricuspid intervention
09 Feb 2025 – From PCR Tokyo Valves 2025
Explore the latest advancements in mitral and tricuspid valve interventions in this comprehensive session. Gain insights into the impact of respiratory dysfunction on mid-term clinical outcomes after M-TEER, the improvements in left atrial structure and function after mitral valve transcatheter edge-to-edge repair, and the use of...
A mindset shift in the cathlab: leveraging contemporary technologies for planning and guiding PCI in complex patients
22 May 2025 – From EuroPCR 2025
This session examines evolving catheterisation lab workflows, highlighting how integrated imaging, physiology, and procedural strategies are reshaping PCI practices. Speakers emphasize the importance of advanced pre-procedural planning using modalities such as intravascular ultrasound (IVUS) to optimise stent deployment, and cardiac computed tomography angiography (CCTA) to improve diagnosis...
A simple low profile solution to the pulmonary embolism problem: EKOS
21 May 2025 – From EuroPCR 2025
Discover a streamlined approach to pulmonary embolism treatment in this EuroPCR 2025 session. Learn how ultrasound-assisted thrombolysis improves right ventricular function and pulmonary perfusion while enabling timely reperfusion with low-dose thrombolytic therapy delivered directly to the clot. Explore the latest data from the HI-PEITHO randomised trial...
Advanced imaging in structural heart disease interventions
20 May 2025 – From EuroPCR 2025
This EuroPCR 2025 session brings together expert insights on the evolving role of 3D intracardiac echocardiography (ICE) in procedures like LAA closure, Mitral TEER, and Tricuspid TEER—highlighting how this advanced modality is reshaping procedural guidance.
You'll also discover how AI-enabled device detection technology is being integrated into...
Advancing renal denervation in China: from guidelines to practice
20 May 2025 – From EuroPCR 2025
Discover how renal denervation (RDN) is rapidly evolving in China to meet the needs of patients with uncontrolled hypertension. This EuroPCR 2025 session highlights recent guideline endorsements and approvals, patient selection based on drug resistance and cardiovascular risk, and the critical role of diagnostic screening. Gain...
Advancing the standard of care in PCI with Bioadaptor: from simple to complex
21 May 2025 – From EuroPCR 2025
This session provides an in-depth overview of Bioadapter technology and its potential to overcome the limitations of current drug-eluting stents (DES) in percutaneous coronary intervention (PCI). Speakers present data from recent trials, including the Bioadapter RCT and the Infinity Sweetheart study, demonstrating a reduction in target lesion...
Align for the future with the Myval Octapro transcatheter heart valve series
20 May 2025 – From EuroPCR 2025
This EuroPCR 2025 session offers a practical and evidence-based update on the Myval Octapro THV. Learn step-by-step techniques for valve-in-valve TAVI using the OctaAlign approach, and understand how intermediate sizes and precise deployment contribute to optimised hemodynamics and long-term durability.
Clinical insights are backed by key data...
Broadening OPTIONs for LAA closure: innovations and outcomes
20 May 2025 – From EuroPCR 2025
Explore the latest insights into LAA closure from EuroPCR 2025. This session highlights results from the OPTION trial—the largest RCT comparing LAAC (with Watchman FLX) to DOAC therapy in AF patients undergoing ablation. The findings? Comparable stroke prevention at 3 years, with a 56 % reduction...
